Viewing Study NCT06848920


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT06848920
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-27
First Post: 2025-01-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma
Sponsor: Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module